Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helgo Magnussen

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Journal of Pain and Symptom Management|August 28, 2012
Episodic breathlessness in patients with advanced disease: a systematic reviewSteffen T Simon, Claudia Bausewein, Eva Schildmann, et al.
Respiration; International Review of Thoracic Diseases|March 15, 2006
Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPDKai Richter, Stephan Stenglein, Marion Mücke, et al.
Pulmonary Pharmacology & Therapeutics|June 1, 2011
Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trialHelgo Magnussen, Henrik Watz, Anne Kirsten, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 31, 2017
Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular functionBenjamin Waschki, Henrik Watz, Olaf Holz, et al.
Chest|June 23, 2009
The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivityHenrik Watz, Benjamin Waschki, Anne Kirsten, et al.
American Journal of Respiratory and Critical Care Medicine|March 25, 2006
Pulmonary biomarkers in chronic obstructive pulmonary diseasePeter J Barnes, Badrul Chowdhury, Sergei A Kharitonov, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter OlympicsSandra D Anderson, Kenneth Fitch, Clare P Perry, et al.
BMC Pulmonary Medicine|March 1, 2008
Assessing airway inflammation in clinical practice - experience with spontaneous sputum analysisOlaf Holz, Tanja Seiler, Andreas Karmeier, et al.
The European Respiratory Journal|June 24, 2017
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot studyHelgo Magnussen, Michael Arzt, Stefan Andreas, et al.
American Journal of Respiratory Cell and Molecular Biology|May 15, 2013
Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3Kumi Yoneda Nagahama, Shinsaku Togo, Olaf Holz, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Journal of Pain and Symptom Management|August 28, 2012
Episodic breathlessness in patients with advanced disease: a systematic reviewSteffen T Simon, Claudia Bausewein, Eva Schildmann, et al.
Respiration; International Review of Thoracic Diseases|March 15, 2006
Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPDKai Richter, Stephan Stenglein, Marion Mücke, et al.
Pulmonary Pharmacology & Therapeutics|June 1, 2011
Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trialHelgo Magnussen, Henrik Watz, Anne Kirsten, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 31, 2017
Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular functionBenjamin Waschki, Henrik Watz, Olaf Holz, et al.
Chest|June 23, 2009
The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivityHenrik Watz, Benjamin Waschki, Anne Kirsten, et al.
American Journal of Respiratory and Critical Care Medicine|March 25, 2006
Pulmonary biomarkers in chronic obstructive pulmonary diseasePeter J Barnes, Badrul Chowdhury, Sergei A Kharitonov, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter OlympicsSandra D Anderson, Kenneth Fitch, Clare P Perry, et al.
BMC Pulmonary Medicine|March 1, 2008
Assessing airway inflammation in clinical practice - experience with spontaneous sputum analysisOlaf Holz, Tanja Seiler, Andreas Karmeier, et al.
The European Respiratory Journal|June 24, 2017
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot studyHelgo Magnussen, Michael Arzt, Stefan Andreas, et al.
American Journal of Respiratory Cell and Molecular Biology|May 15, 2013
Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3Kumi Yoneda Nagahama, Shinsaku Togo, Olaf Holz, et al.
Pageof 13